Torque Teno Virus in Kidney Transplant Recipients: Perspectives on Its Role as a Complementary Marker in Monitoring Net Immunosuppression
Journal of Clinical Medicine · 17.06.2026 · 15 (12) · 4682
DOI: 10.3390/jcm15124682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.06.2026. Verfasst von Patryk Wawrzonkowski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Transplantation Medicine and Internal Diseases, Institute of Internal Diseases, Wroclaw Medical University, 50-551 Wroclaw,…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Monitoring immunosuppression in kidney transplant recipients remains challenging, as conventional therapeutic drug monitoring (TDM) reflects pharmacokinetic exposure rather than the overall functional immune state. Torque teno virus (TTV), a non-pathogenic virus, has emerged as a potential complementary biomarker of the net state of immunosuppression. This review evaluates the current evidence regarding the utility of TTV load in this context, focusing on its correlation with standard pharmacokinetic markers, the analytical performance of quantitative PCR assays, its role as an integrated marker of immunosuppression, and its predictive value for clinical outcomes. Available data indicate that TTV load shows weak and inconsistent correlations with individual drug levels, such as tacrolimus trough concentrations, supporting its role as a complementary rather than substitutive tool. qPCR-based assays demonstrate generally good sensitivity and reproducibility, although inter-assay variability and lack of standardization remain important limitations. Clinically, higher TTV levels have been associated with an increased risk of opportunistic infections, whereas lower levels have been linked to acute rejection, suggesting a potential association between TTV viremia and immune status. TTV monitoring may represent a promising complementary approach for a more individualized assessment of immunosuppression. However, further prospective and interventional studies are required to validate standardized thresholds and determine whether TTV-guided strategies improve transplant outcomes compared with conventional monitoring.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Transplantation Medicine and Internal Diseases, Institute of Internal Diseases, Wroclaw Medical University, 50-551 Wroclaw, Poland.
- University Clinical Hospital in Wroclaw, Borowska 213, 50-556 Wroclaw, Poland.
ORCID-Profile: Patryk Wawrzonkowski, Jakub Mizera, Mirosław Banasik
Förderung
- Wroclaw Medical University
Zitieren
APA
Wawrzonkowski, P., Mizera, J., Zachciał, J., & Banasik, M. (2026). Torque Teno Virus in Kidney Transplant Recipients: Perspectives on Its Role as a Complementary Marker in Monitoring Net Immunosuppression. Journal of Clinical Medicine, 15(12), 4682. https://doi.org/10.3390/jcm15124682
Vancouver
Wawrzonkowski P, Mizera J, Zachciał J, Banasik M. Torque Teno Virus in Kidney Transplant Recipients: Perspectives on Its Role as a Complementary Marker in Monitoring Net Immunosuppression. Journal of Clinical Medicine. 2026;15(12):4682. doi:10.3390/jcm15124682
BibTeX
@article{Wawrzonkowski2026,
author = {Wawrzonkowski, Patryk and Mizera, Jakub and Zachciał, Justyna and Banasik, Mirosław},
title = {Torque Teno Virus in Kidney Transplant Recipients: Perspectives on Its Role as a Complementary Marker in Monitoring Net Immunosuppression},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4682},
doi = {10.3390/jcm15124682}
}
EUVIMED